03:29 PM EDT, 10/29/2025 (MT Newswires) -- Needham is maintaining its Hold on Bausch + Lomb ( BLCO ) shares while acknowledging the company's third-quarter earnings beat. Revenue was also in-line with consensus.

"While 3Q25 was a solid quarter, we maintain our Hold rating given uncertainty around BLCO's separation from parent Bausch Health Companies," Needham writes.

Bausch + Lomb's ( BLCO ) recent and upcoming product launches will also help it sustain mid-single digit revenue growth. "While we believe new products can contribute more meaningfully in 2025/2026, we believe there is limited upside to consensus estimates in the meantime," Needham notes, adding that analysts would like more clarity around the timing of Bausch + Lomb's ( BLCO ) separation from its parent Bausch Health.

Price: 21.60, Change: +0.45, Percent Change: +2.13